Evaxion Biotech Q4 EPS $(0.39) Down From $(0.27) YoY

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.39) per share. This is a 44.44 percent decrease over losses of $(0.27) per share from the same period last year.

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.39) per share. This is a 44.44 percent decrease over losses of $(0.27) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

The Dow Jones Industrial Average Turns 125

The Dow turned 125 in May, but it’s hardly in a retiring mood. The oft-cited stock index originated during a time when smokestacks and slaughterhouses dominated the American economy, but today’s Dow very much reflects our digital age. Plus, everyone knows what it is and what it stands for, said Jamie Farmer, chief commercial officer with S&P Dow Jones Indices.

AAPL